High Tide Inc. announced strong financial results for Q2 2026, highlighting record revenue of $31.6 million from its German cannabis subsidiary Remexian Pharma, with gross margins rising to 27%. The company secured $40 million in senior secured credit facilities from the Bank of Montreal to support further growth without diluting shares. Canadian membership in its Cabana Club grew 39% to over 2.65 million, with elite members up 84%, maintaining High Tide's position as the top cannabis revenue generator in Canadian dollars and holding a 12% retail market share across five provinces. These results demonstrate High Tide's expanding footprint and financial strength in the cannabis sector.
Veea Inc. has announced the commercial release of VeeaONE, a full-stack AI infrastructure platform that integrates edge-to-cloud hardware and software. The platform supports VeeaWare middleware on NVIDIA Jetson and x86/Arm servers, enabling secure, l...
Virtuals Protocol has introduced customizable tokenized indexes on the Robinhood Chain, allowing users to combine multiple assets into a single token. This innovation enables users to create and manage their own asset baskets and earn fees when other...
US spot Bitcoin ETFs saw net inflows of $107.8 million on Wednesday, while Ethereum ETFs attracted $53.8 million, signaling renewed institutional interest in crypto funds. Since their launch in January 2024, Bitcoin ETFs have accumulated over $51 bil...
Kaia has signed a strategic partnership with Xilo Labs to integrate Mochi, an onchain asset management platform, into Kaia's ecosystem. This collaboration allows users to invest stablecoins into diversified portfolios backed by tokenized real-world a...
Bitcoin's price surged to nearly $65,000 following softer-than-expected U.S. inflation data for June, easing fears of Federal Reserve rate hikes. However, on-chain data reveals two main groups of investors—long-term holders who bought near last year'...
